Abstract
Stomach cancer is fifth in incidence and third in mortality worldwide. Patients are often diagnosed late, with fewer therapeutic options and poorer survival. In this scenario, low molecular weight protein tyrosine phosphatase (LMWPTP) emerges as a target to increase therapeutic efficacy, as it participates in a molecular network responsible for providing some advantages for tumor cells th…